Category Venues

Report: European Patent Office Tapped Computers

A story in the German newspaper Süddeutsche Zeitung says, according to an unofficial translation, that it has obtained an internal report that shows the European Patent Office (EPO) tapped two general use computers it had identified as a source for leaked information. The news comes on the eve of a meeting of the EPO president with the European Parliament.

LDC Pharma Extension Request At WTO Yields Support But Needs Further Discussion

World Trade Organization members this week could not decide on a request from least-developed countries to extend a waiver allowing them to forego the enforcement of intellectual property rights on pharmaceutical products until their economies are stronger. Discussions are expected to be conducted informally until the next meeting of the organisation’s council on IP rights in October.

EU Sees Flurry Of IP Policy Activity

With European Commission proposals for copyright reform expected later this year, EU lawmakers, rights-holders and digital rights activists are pushing for major policy shifts. European Parliament resolutions approved on 9 June call for stronger intellectual property protections in non-EU countries, and better internal enforcement against online breaches. A controversial draft report seeking more harmonisation of EU copyright measures has attracted around 600 proposed amendments and will be voted on 16 June. Meanwhile, the Council said it reached agreement with Parliament on changes to EU trademark law.

US Shifts Stance On Drug Pricing In Pacific Trade Pact Talks, Document Reveals

From the New York Times: WASHINGTON — Facing resistance from its Pacific trading partners, the Obama administration is no longer demanding protection for pharmaceutical prices under the 12-nation Trans-Pacific Partnership, according to a newly leaked “transparency” annex of the proposed trade accord.

But American negotiators are still pressing participating governments to open up the process that sets reimbursement rates for drugs and medical devices. Public health professionals, generic drugmakers and activists opposed to the trade deal, which is still being negotiated, contend that it will empower big pharmaceutical firms to command higher reimbursement rates in the United States and abroad, at the expense of consumers.

Tumultuous Session In European Parliament Ends In Postponement Of TTIP Debate

After a tumultuous early morning session today in Strasbourg, a slim majority of 183 (against 181) members of the European Parliament decided to postpone mere debate of the Parliament's report on the Transatlantic Trade and Investment Partnership (TTIP). The vote on the report prepared by Bernd Lange, head of the International Trade Committee (S&D), had already been postponed yesterday by the President of the Parliament, Martin Schulz.

Climate Change Headlines G7; Merkel Commits To Conclude TTIP During Obama’s Term

MUNICH -- The agreement of the heads of states of the United States, Canada, Japan, United Kingdom, France, Italy and Germany to reduce global warning to less than two degrees made the biggest headlines of the G7 Summit on Elmau Castle, Germany, in the Bavarian Alps. Also agreed were commitments on trade and on public health, including research and development for neglected diseases.

US Approves New Loophole In Patent Protection

The US Federal Circuit Court of Appeals clearly likes patents. Over the years, the court has issued a long string of rulings that greatly strengthened the rights of patent owners. But several weeks ago, in Akamai Technologies v. Limelight Networks, the court reluctantly created a major loophole in patent protection.